Clinical Trial Update: Intralymphatic Immunotherapy in Increasing Doses, Substudy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on intralymphatic immunotherapy with increasing doses for seasonal allergic rhinitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Snippet

Sponsor: Karolinska Institutet | Conditions: Rhinitis, Allergic, Seasonal | Phase 2, Phase 3 | Status: COMPLETED